Navigation Links
USP announces new standards to protect patients from counterfeit and adulterated medicines

Rockville, Md., February 4, 2009 With counterfeit and adulterated medicines posing an increasing risk to patients in the United States and worldwide, the U.S. Pharmacopeial (USP) Convention today announces new standards for two widely used drug products that have been involved in episodes of adulteration resulting in patient deaths.

The release of these standards, for the blood thinner heparin and the sweetener glycerin, comes on the heels of recent and dangerous incidents involving the two products. More than 200 patients worldwide reportedly died after batches of heparin were adulterated with over-sulfated chondroitin sulfatewhich can be derived from the dietary supplement chondroitin and can mimic heparin's blood-thinning properties. Glycerin, used in many drugs and consumer goods such as cough syrups and toothpaste, has been involved in numerous episodes in which diethylene glycol, a poisonous chemical used in antifreeze, was added either intentionally or accidentally as a lower-cost substitute for glycerin, most recently in Nigeria in 2008.

"The tragedies involving heparin and glycerin demonstrate the shortcomings of 20th century safety nets in a 21st century global manufacturing supply chain," noted Roger L. Williams, M.D., USP's chief executive officer. "The reality is that with the decentralized, complex and global nature of today's manufacturing environment, it is too easy for an unscrupulous supplierdriven by economic or even more frightening motivesto add an ingredient to a drug product that shouldn't be there, putting us all at risk. These suppliers are increasingly sophisticated in their methods, resulting in a very dangerous situation. Rigorous quality standards such as the ones announced today form a line of defense that helps to protect the public. "

"These new USP quality standards provide better assurance of the quality of marketed products by using appropriate and modern analytical methods," says Moheb Nasr, Ph.D., director, Office of New Drug Quality Assessment (ONDQA), CDER, FDA. "This provides a considerable safeguard for citizens of the United States and the world by helping to prevent fraudulent suppliers from adding components that in the past have eluded existing identity tests due to similar properties. The new standards represent a significant improvement to the safety nets that keep substandard drugs from reaching the marketplace. FDA is pleased to have worked together with USP on this effort."


Contact: Sandra Kim
US Pharmacopeia

Related medicine news :

1. dLifeTV Announces New Season Programming and Celebrity Guests; Only Nationally-Broadcast Program About Diabetes Celebrates 5th Year and 200th Show
2. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
3. Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
4. Cielo MedSolutions Announces Strong Revenue Growth in 2008
5. Express Scripts Announces Fourth Quarter 2008 Earnings Conference Call
6. Healthcare Realty Trust Announces Fourth Quarter Dividend
7. BD Announces Results of Shareholder Votes at Annual Meeting
8. UV Foundation Announces: February is Vitamin D Deficiency Month
9. Favrille Announces Name Change to MMR Information Systems, Inc. Following Completion of Merger With MyMedicalRecords, Inc.
10. Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate
11. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Olympic Gold Medalists and Celebrity ... brands across various categories through traditional and social media marketing campaigns and other ... of Gold Medal Moms who can connect with today’s most important consumer: mothers. ...
(Date:11/30/2015)... ... December 01, 2015 , ... The ... a 2015-2016 inductee into its VIP Woman of the Year Circle. She is ... leading networking organization exclusively for professional women, boasting 850,000 members and over 200 ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... (Meso Foundation) released information for caregivers and held two webinars on topics of ... on demand free of charge at . , With a loved ...
(Date:11/30/2015)... ... November 30, 2015 , ... MOSI recently added two state-of-the-art augmented reality (AR) ... the Jurassic to their collection of interactive exhibits within the Kids In Charge! building. ... allow guests to get closer than ever to a range of animals as they ...
(Date:11/30/2015)... VA (PRWEB) , ... November 30, 2015 , ... ... mesothelioma-affected community across the United States to access life-saving information provided ... Malignant Mesothelioma will consist of three individual conferences in three major cities: ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  QT Vascular Ltd., ... and together with its subsidiaries, TriReme Medical LLC and ... company engaged in the design, assembly and distribution of ... vascular disease, is pleased to announce that a three-judge ... Court of Appeals for the Federal Circuit ("Federal Circuit") ...
(Date:11/30/2015)... 2015   Royal Philips  (NYSE: PHG ... Radiology Solutions, a fully integrated, consultative approach to ... data-driven practice management approaches that combine imaging systems, ... improve care delivery and reduce costs. Making its ... North America Annual Meeting (RSNA) in ...
(Date:11/30/2015)... -- Nautilus Medical Inc. today announced worldwide availability of ... ). The release of MatrixRay to the entire medical ... North America) in Chicago - ... --> --> MatrixRay is the ... studies worldwide via a peer-to-peer exchange network of physicians ...
Breaking Medicine Technology: